CosmoFarm posts record Q2 2026 revenue above $15M

Cosmos Health Inc. (NASDAQ: COSM) announced that its wholly owned subsidiary, CosmoFarm S.A., reported revenue of more than $15 million in the second quarter of 2026, representing an annualized run-rate of over $60 million, according to a press release from the company.

CosmoFarm added more than 80 new pharmacies to its distribution network during the quarter. The subsidiary operates as a pharmaceutical wholesaler in the greater Athens area.

Cosmos Health said it is increasing capital expenditure at CosmoFarm, with investments directed toward robotic automation and artificial intelligence systems covering procurement, inventory management, and order fulfillment. The company is also expanding CosmoFarm's physical facility to accommodate higher volumes.

The new investments build on existing automated infrastructure at the facility, including ROWA and SSI Schäfer A-frame robotic systems.

Greg Siokas, CEO of Cosmos Health, said: "CosmoFarm's record second quarter marks an important milestone, with revenue reaching an annualized run-rate of over $60 million. The addition of over 80 new pharmacies reflects the strength of our distribution platform and the trust of our growing customer base."

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
• Getty Realty discloses separation terms for departing accounting officer